Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.31 trillion and total revenue of $109.84 billion.
Market Cap
1.31T
Revenue
109.84B
Profits
-41.24B
PE Ratio
n/a
Profit Margin
-37.54%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.55B | -1.39% | 2,292,765 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.80B | 4.07% | 918,938 | 14.92B |
| 3 | ARGX | argenx SE | 57.72B | 0.34% | 385,317 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.94B | 2.73% | 980,353 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.49B | 0.25% | 1,893,446 | - |
| 6 | ONC | BeOne Medicines AG | 34.35B | -0.16% | 311,109 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.28B | 1.55% | 2,611,160 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 31.65B | -2.48% | 8,688,341 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.12B | 2.60% | 6,065,982 | 8.26M |
| 10 | INSM | Insmed Incorporated | 24.46B | 1.17% | 1,660,514 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.84B | 0.38% | 896,002 | 3.23B |
| 12 | INCY | Incyte Corporation | 23.58B | 2.10% | 1,563,446 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.80B | 4.18% | 1,533,870 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.58B | -0.35% | 627,614 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.56B | 1.45% | 1,056,540 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.27B | 0.21% | 2,694,494 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.35B | 2.79% | 3,334,535 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 14.27B | 3.79% | 2,646,683 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.85B | 2.95% | 1,055,980 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.57B | 3.00% | 318,420 | 1.13B |
| 21 | ABVX | ABIVAX Société Anonyme | 12.49B | -1.26% | 1,356,009 | 5.67M |
| 22 | SMMT | Summit Therapeutics Inc. | 12.33B | -0.31% | 2,798,305 | - |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.25B | 0.49% | 1,914,684 | 622.01M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.66B | 2.65% | 1,598,602 | 3.24B |
| 25 | CYTK | Cytokinetics, Incorporated | 11.62B | -0.01% | 2,293,371 | 105.82M |
| 26 | TECH | Bio-Techne Corporation | 11.00B | -0.44% | 5,483,257 | 1.21B |
| 27 | KRYS | Krystal Biotech, Inc. | 10.87B | -1.62% | 274,648 | 417.30M |
| 28 | CORT | Corcept Therapeutics Incorporated | 10.10B | 2.65% | 1,141,967 | 769.10M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.03% | 1,054,045 | - |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.81B | 3.90% | 830,883 | 51.48M |
| 31 | NUVL | Nuvalent, Inc. | 9.79B | 0.04% | 1,077,918 | - |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.68B | 0.98% | 2,027,123 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 9.17B | -1.68% | 11,232,609 | 140.98M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 9.06B | 7.11% | 1,374,228 | 74.06M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 9.03B | 3.33% | 579,503 | 7.46M |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | 98.74% | 80,950,471 | 18.07M |
| 37 | PCVX | Vaxcyte, Inc. | 8.76B | 6.51% | 1,513,685 | - |
| 38 | IMVT | Immunovant, Inc. | 8.23B | 3.86% | 2,217,023 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 8.23B | 4.67% | 2,105,178 | 700.35M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 8.18B | 6.19% | 1,305,747 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.84B | 2.49% | 998,549 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.82B | 5.25% | 902,349 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 7.40B | 4.40% | 1,410,792 | 827.11M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.84B | 1.45% | 3,723,013 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.78B | 2.17% | 1,144,016 | - |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | -0.31% | 316,466 | 274.48M |
| 47 | BLTE | Belite Bio, Inc | 6.20B | 2.38% | 222,510 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 6.13B | 4.67% | 1,442,839 | 7.50M |
| 49 | CGON | CG Oncology, Inc. | 6.10B | -0.09% | 967,906 | 5.07M |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.90B | 0.34% | 2,588,242 | - |
| 51 | CRSP | CRISPR Therapeutics AG | 5.86B | -1.81% | 1,668,177 | 4.10M |
| 52 | ERAS | Erasca, Inc. | 5.71B | -2.60% | 5,241,555 | - |
| 53 | CELC | Celcuity Inc. | 5.64B | 6.58% | 1,453,658 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.38B | 0.64% | 1,273,325 | 536.20M |
| 55 | LEGN | Legend Biotech Corporation | 5.35B | -1.28% | 1,174,075 | 1.14B |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 5.23B | 2.59% | 819,570 | 1.34M |
| 57 | ORKA | Oruka Therapeutics, Inc. | 5.10B | 1.65% | 2,202,748 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.94B | -1.91% | 2,647,704 | 907.29M |
| 59 | VKTX | Viking Therapeutics, Inc. | 4.89B | 8.83% | 4,359,881 | - |
| 60 | MANE | Veradermics, Incorporated | 4.88B | -4.32% | 385,413 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.64B | 7.56% | 1,281,052 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | 1.67% | 1,674,441 | 1.10B |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.36B | 0.60% | 2,795,507 | 56.99M |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 4.32B | 5.99% | 958,652 | 22.57M |
| 65 | RLAY | Relay Therapeutics, Inc. | 4.30B | 4.44% | 5,144,547 | 10.68M |
| 66 | DNLI | Denali Therapeutics Inc. | 4.18B | 2.21% | 1,437,163 | - |
| 67 | GPCR | Structure Therapeutics Inc. | 4.02B | 3.43% | 608,000 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.98B | -3.37% | 174,005 | 803.79M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.94B | 4.33% | 3,058,895 | - |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.86B | 3.94% | 508,629 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.03% | 780,045 | 596.96M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | 2.90% | 1,478,929 | 225.27M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.80B | 0.90% | 794,369 | 236.00M |
| 74 | BEAM | Beam Therapeutics Inc. | 3.77B | 7.36% | 3,941,683 | 164.01M |
| 75 | ALMS | Alumis Inc. | 3.73B | 7.33% | 3,121,045 | 8.40M |
| 76 | ELVN | Enliven Therapeutics, Inc. | 3.56B | 1.82% | 2,011,676 | - |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.52B | 6.44% | 4,421,403 | 670.00M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 6.14% | 2,397,370 | 415.62M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.13B | 5.22% | 1,701,290 | 865.00K |
| 80 | VERA | Vera Therapeutics, Inc. | 3.08B | 7.05% | 5,122,357 | - |
| 81 | IRON | Disc Medicine, Inc. | 3.05B | 3.57% | 1,243,606 | - |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | 5.22% | 1,347,505 | 535.08M |
| 83 | MBX | MBX Biosciences, Inc. | 2.95B | 7.45% | 756,531 | - |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.88B | -4.55% | 1,648,201 | - |
| 85 | QURE | uniQure N.V. | 2.85B | 0.12% | 2,220,952 | 18.09M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.77B | 8.64% | 5,526,520 | - |
| 87 | IMNM | Immunome, Inc. | 2.76B | 2.05% | 1,561,508 | 4.02M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.69B | 4.60% | 1,234,754 | - |
| 89 | SLS | SELLAS Life Sciences Group, Inc. | 2.65B | -3.16% | 8,164,662 | - |
| 90 | AGIO | Agios Pharmaceuticals, Inc. | 2.62B | 17.71% | 2,776,224 | 66.05M |
| 91 | NKTR | Nektar Therapeutics | 2.53B | 2.39% | 1,573,369 | 55.63M |
| 92 | NRIX | Nurix Therapeutics, Inc. | 2.52B | 1.50% | 1,239,691 | 71.78M |
| 93 | NTLA | Intellia Therapeutics, Inc. | 2.44B | -2.30% | 3,171,882 | 66.09M |
| 94 | PHVS | Pharvaris N.V. | 2.42B | 4.12% | 972,781 | - |
| 95 | VCEL | Vericel Corporation | 2.40B | 0.84% | 422,919 | 292.09M |
| 96 | KOD | Kodiak Sciences Inc. | 2.39B | 3.46% | 566,227 | - |
| 97 | ABCL | AbCellera Biologics Inc. | 2.35B | -2.29% | 8,059,824 | 79.21M |
| 98 | BHVN | Biohaven Ltd. | 2.34B | -3.12% | 2,946,765 | - |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.26B | 6.94% | 2,873,805 | 52.04M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 2.26B | 7.79% | 3,477,254 | 70.92M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | 3.38% | 846,978 | 899.11M |
| 102 | ZLAB | Zai Lab Limited | 2.17B | 1.42% | 606,067 | 453.28M |
| 103 | ADMA | ADMA Biologics, Inc. | 2.13B | 0.55% | 2,331,692 | 509.86M |
| 104 | KARD | Kardigan, Inc. | 2.13B | 0.21% | 272,986 | - |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.09B | 4.03% | 152,930 | - |
| 106 | SRPT | Sarepta Therapeutics, Inc. | 2.09B | 3.18% | 2,434,515 | 2.18B |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 4.71% | 2,672,095 | 298.30M |
| 108 | GENB | Generate Biomedicines, Inc. | 2.08B | -4.14% | 921,763 | 30.30M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 2.08B | 1.88% | 3,680,516 | 7.47M |
| 110 | GLUE | Monte Rosa Therapeutics, Inc. | 2.06B | 4.95% | 1,303,443 | 42.95M |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | 5.25% | 2,294,494 | 217.17M |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.06B | 1.82% | 904,585 | 32.08M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 2.04B | -3.03% | 28,855,557 | 66.41M |
| 114 | SION | Sionna Therapeutics, Inc. | 2.03B | 4.20% | 664,396 | - |
| 115 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.86% | 156,200 | 1.20B |
| 116 | BCAX | Bicara Therapeutics Inc. | 2.00B | 4.04% | 1,840,181 | - |
| 117 | ANAB | AnaptysBio, Inc. | 1.99B | 8.05% | 947,775 | 232.39M |
| 118 | NUVB | Nuvation Bio Inc. | 1.97B | 1.25% | 7,144,129 | 143.05M |
| 119 | PGEN | Precigen, Inc. | 1.96B | -1.61% | 7,508,470 | 31.60M |
| 120 | ZYME | Zymeworks Inc. | 1.95B | 5.49% | 771,623 | 81.26M |
| 121 | IOVA | Iovance Biotherapeutics, Inc. | 1.94B | 3.82% | 11,624,837 | 285.61M |
| 122 | ABSI | Absci Corporation | 1.92B | -1.82% | 4,153,947 | 1.84M |
| 123 | NBTX | Nanobiotix S.A. | 1.92B | -5.60% | 108,271 | 38.27M |
| 124 | ATAI | AtaiBeckley Inc. | 1.91B | 4.64% | 7,712,534 | 3.49M |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 2.98% | 860,314 | 20.00M |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.50% | 754,577 | - |
| 127 | DMRA | Damora Therapeutics, Inc. | 1.85B | 0.60% | 588,472 | - |
| 128 | GHRS | GH Research PLC | 1.84B | 2.75% | 155,275 | - |
| 129 | URGN | UroGen Pharma Ltd. | 1.84B | 0.91% | 914,033 | 140.49M |
| 130 | MESO | Mesoblast Limited | 1.83B | -0.28% | 211,470 | 65.38M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.82B | 1.51% | 628,597 | 20.00M |
| 132 | ZBIO | Zenas BioPharma, Inc. | 1.75B | 4.65% | 898,535 | 10.00M |
| 133 | VIR | Vir Biotechnology, Inc. | 1.73B | 2.30% | 1,352,409 | 65.50M |
| 134 | IMCR | Immunocore Holdings plc | 1.70B | 4.57% | 1,195,665 | 412.81M |
| 135 | MPLT | MapLight Therapeutics, Inc. | 1.68B | 5.76% | 588,335 | - |
| 136 | FTRE | Fortrea Holdings Inc. | 1.65B | -2.07% | 1,229,229 | 2.71B |
| 137 | AAPG | Ascentage Pharma Group International | 1.65B | -3.56% | 7,835 | 82.08M |
| 138 | INVA | Innoviva, Inc. | 1.64B | 1.97% | 513,398 | 420.69M |
| 139 | SEPN | Septerna, Inc. | 1.62B | 7.05% | 843,500 | 72.26M |
| 140 | AVBP | ArriVent BioPharma, Inc. | 1.59B | -0.90% | 402,315 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.58B | 1.43% | 1,386,362 | - |
| 142 | SVRA | Savara Inc. | 1.57B | 0.16% | 2,360,654 | - |
| 143 | NVAX | Novavax, Inc. | 1.56B | 1.18% | 4,516,820 | 596.34M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.53B | 0.34% | 2,625,160 | 204.73M |
| 145 | AKTS | Aktis Oncology, Inc. | 1.52B | 3.84% | 498,425 | 8.28M |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.47B | 3.47% | 459,447 | 1.30M |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.47B | 5.07% | 162,036 | - |
| 148 | IMTX | Immatics N.V. | 1.40B | 2.70% | 401,258 | 43.00M |
| 149 | MGTX | MeiraGTx Holdings plc | 1.36B | 5.54% | 2,019,323 | 79.76M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.33B | 5.40% | 1,042,841 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.33B | 0.75% | 4,576,020 | 427.68M |
| 152 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | 3.03% | 1,339,830 | - |
| 153 | MNKD | MannKind Corporation | 1.30B | -1.17% | 3,394,110 | 360.78M |
| 154 | CAPR | Capricor Therapeutics, Inc. | 1.29B | -0.94% | 1,447,504 | 11.13M |
| 155 | AVLN | Avalyn Pharma Inc. | 1.26B | 2.78% | 406,256 | - |
| 156 | SANA | Sana Biotechnology, Inc. | 1.24B | 3.78% | 3,728,982 | - |
| 157 | WVE | Wave Life Sciences Ltd. | 1.23B | 0.95% | 2,738,218 | 71.80M |
| 158 | EYPT | EyePoint, Inc. | 1.18B | -2.91% | 2,117,886 | 7.61M |
| 159 | XNCR | Xencor, Inc. | 1.16B | 5.24% | 719,118 | 97.36M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -6.08% | 1,076,638 | - |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -0.18% | 2,449,996 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | 1.91% | 715,223 | - |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 1.10B | -1.10% | 1,597,484 | - |
| 164 | SLDB | Solid Biosciences Inc. | 1.10B | 0.72% | 1,416,332 | - |
| 165 | VOR | Vor Biopharma Inc. | 1.09B | - | 1,369,268 | - |
| 166 | KURA | Kura Oncology, Inc. | 1.06B | 8.61% | 3,812,049 | 71.64M |
| 167 | ANNX | Annexon, Inc. | 1.05B | 7.89% | 5,759,434 | - |
| 168 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | 2.16% | 4,745,075 | 69.64M |
| 169 | ABUS | Arbutus Biopharma Corporation | 1.02B | 4.23% | 5,089,824 | 191.45M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -3.56% | 1,443,023 | 59.00K |
| 171 | PHAR | Pharming Group N.V. | 1.01B | 1.05% | 4,634 | 369.49M |
| 172 | JANX | Janux Therapeutics, Inc. | 986.42M | 4.96% | 1,290,072 | 13.73M |
| 173 | LBRX | LB Pharmaceuticals Inc | 983.32M | 2.63% | 412,098 | - |
| 174 | SPTX | Seaport Therapeutics, Inc. | 975.86M | -5.89% | 157,910 | - |
| 175 | DBVT | DBV Technologies S.A. | 971.84M | 11.15% | 366,103 | 5.74M |
| 176 | REPL | Replimune Group, Inc. | 966.21M | 0.35% | 2,097,143 | - |
| 177 | GERN | Geron Corporation | 955.87M | 3.47% | 11,479,010 | 196.12M |
| 178 | DSGN | Design Therapeutics, Inc. | 918.74M | -0.94% | 1,136,535 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 917.42M | 1.49% | 1,358,957 | 204.89M |
| 180 | ANRO | Alto Neuroscience, Inc. | 901.91M | -1.98% | 662,935 | - |
| 181 | IVA | Inventiva S.A. | 897.76M | 16.92% | 3,292,484 | 7.94M |
| 182 | TENX | Tenax Therapeutics, Inc. | 887.97M | 6.89% | 1,639,905 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 881.60M | 0.06% | 889,567 | 109.78M |
| 184 | IMMX | Immix Biopharma, Inc. | 855.70M | 15.02% | 4,242,865 | - |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 853.62M | 3.36% | 1,875,994 | 122.29M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 835.98M | 0.79% | 3,194,681 | 35.54M |
| 187 | OCS | Oculis Holding AG | 818.86M | -1.74% | 505,334 | 1.40M |
| 188 | SPRY | ARS Pharmaceuticals, Inc. | 813.29M | -1.68% | 1,235,227 | 98.99M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 787.45M | 5.71% | 744,385 | 299.77M |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 784.91M | 2.37% | 1,379,917 | 8.37M |
| 191 | RGNX | REGENXBIO Inc. | 776.50M | 1.28% | 2,757,114 | 87.82M |
| 192 | AURA | Aura Biosciences, Inc. | 775.40M | -0.85% | 814,985 | - |
| 193 | CLYM | Climb Bio, Inc. | 768.44M | 1.13% | 1,365,731 | - |
| 194 | ODTX | Odyssey Therapeutics, Inc. | 761.74M | -3.40% | 229,331 | 1.06M |
| 195 | OMER | Omeros Corporation | 747.64M | -0.10% | 1,236,194 | 9.89M |
| 196 | ALLO | Allogene Therapeutics, Inc. | 742.08M | 2.87% | 14,391,755 | 22.00K |
| 197 | NGNE | Neurogene Inc. | 733.31M | 13.02% | 707,987 | 925.00K |
| 198 | CADL | Candel Therapeutics, Inc. | 721.71M | -1.79% | 1,575,841 | - |
| 199 | SLBT | SL Science Holding Limited | 720.85M | -5.41% | 93,990 | - |
| 200 | PRME | Prime Medicine, Inc. | 720.66M | - | 4,131,846 | 4.03M |
| 201 | CRMD | CorMedix Inc. | 695.87M | 0.91% | 841,645 | 400.05M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 690.17M | -1.30% | 566,843 | - |
| 203 | TECX | Tectonic Therapeutic, Inc. | 689.39M | 3.73% | 365,073 | - |
| 204 | FTH | Faeth Therapeutics, Inc. | 673.08M | 6.61% | 166,637 | - |
| 205 | RLMD | Relmada Therapeutics, Inc. | 672.35M | 1.26% | 1,869,428 | - |
| 206 | FDMT | 4D Molecular Therapeutics, Inc. | 670.18M | 0.79% | 650,767 | 88.24M |
| 207 | ACHV | Achieve Life Sciences, Inc. | 669.34M | 1.09% | 1,732,125 | - |
| 208 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 664.09M | -1.43% | 369,376 | - |
| 209 | AGMB | AgomAb Therapeutics NV | 654.01M | -1.78% | 97,744 | - |
| 210 | SGP | SpyGlass Pharma, Inc. | 652.62M | 2.25% | 106,210 | - |
| 211 | GYRE | Gyre Therapeutics, Inc. | 640.52M | -3.72% | 106,079 | 117.05M |
| 212 | DRUG | Bright Minds Biosciences Inc. | 639.81M | -3.98% | 254,113 | - |
| 213 | MNPR | Monopar Therapeutics Inc. | 637.86M | -1.96% | 163,567 | - |
| 214 | EIKN | Eikon Therapeutics, Inc. | 626.93M | -3.74% | 443,140 | - |
| 215 | MDXG | MiMedx Group, Inc. | 625.57M | 3.19% | 1,478,179 | 389.42M |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 610.13M | -7.62% | 1,161,859 | 151.40M |
| 217 | NVCT | Nuvectis Pharma, Inc. | 605.29M | -2.19% | 425,429 | - |
| 218 | PROK | ProKidney Corp. | 589.02M | -2.01% | 1,039,043 | 889.00K |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 588.50M | 5.68% | 1,200,913 | - |
| 220 | ALT | Altimmune, Inc. | 587.31M | -1.95% | 4,619,672 | 36.00K |
| 221 | EDIT | Editas Medicine, Inc. | 575.48M | 2.74% | 2,819,404 | 38.69M |
| 222 | ASMB | Assembly Biosciences, Inc. | 574.01M | 0.22% | 177,789 | 71.10M |
| 223 | CBIO | Crescent Biopharma, Inc. | 565.89M | 0.41% | 222,818 | 11.88M |
| 224 | STTK | Shattuck Labs, Inc. | 556.70M | 0.28% | 1,427,433 | 1.00M |
| 225 | ARVN | Arvinas, Inc. | 554.24M | 1.54% | 844,416 | 89.40M |
| 226 | XOMA | XOMA Royalty Corporation | 550.43M | 0.09% | 144,744 | 48.56M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 543.78M | -6.34% | 491,420 | - |
| 228 | FBRX | Forte Biosciences, Inc. | 543.69M | 9.02% | 500,696 | - |
| 229 | STRO | Sutro Biopharma, Inc. | 532.41M | 4.90% | 583,113 | 99.61M |
| 230 | RZLT | Rezolute, Inc. | 519.20M | 0.81% | 1,545,383 | - |
| 231 | OVID | Ovid Therapeutics Inc. | 515.13M | 5.75% | 3,312,876 | 7.12M |
| 232 | OCGN | Ocugen, Inc. | 507.78M | 0.67% | 4,757,366 | 4.47M |
| 233 | PRTA | Prothena Corporation plc | 506.78M | 1.79% | 520,542 | 57.94M |
| 234 | CABA | Cabaletta Bio, Inc. | 505.47M | 2.99% | 7,490,109 | - |
| 235 | VALN | Valneva SE | 495.19M | -2.59% | 26,640 | 180.25M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 492.91M | -0.40% | 320,070 | 16.72M |
| 237 | ZURA | Zura Bio Limited | 482.59M | -5.22% | 1,261,488 | - |
| 238 | CCCC | C4 Therapeutics, Inc. | 480.97M | 5.07% | 4,373,743 | 34.86M |
| 239 | EVMN | Evommune, Inc. | 480.49M | 7.93% | 1,925,441 | 10.00M |
| 240 | SLN | Silence Therapeutics plc | 479.42M | -4.06% | 617,557 | 839.00K |
| 241 | SGMT | Sagimet Biosciences Inc. | 474.87M | -0.65% | 1,341,023 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 462.58M | 2.01% | 110,416 | - |
| 243 | ARTV | Artiva Biotherapeutics, Inc. | 460.62M | 0.42% | 315,985 | 251.00K |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 444.42M | 2.01% | 2,366,566 | - |
| 245 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.42M | 1.99% | 252,885 | - |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 430.53M | -0.25% | 270,438 | - |
| 247 | AUTL | Autolus Therapeutics plc | 428.49M | -1.23% | 755,323 | 92.62M |
| 248 | ANL | Adlai Nortye Ltd. | 428.00M | -2.01% | 239,570 | 5.00M |
| 249 | UPB | Upstream Bio, Inc. | 427.74M | 6.22% | 726,125 | 3.32M |
| 250 | VSTM | Verastem, Inc. | 426.19M | 8.74% | 2,851,754 | 49.59M |
| 251 | VTVT | vTv Therapeutics Inc. | 423.41M | -1.22% | 89,538 | 36.84M |
| 252 | CMPX | Compass Therapeutics, Inc. | 417.80M | 1.31% | 3,212,752 | 850.00K |
| 253 | IPSC | Century Therapeutics, Inc. | 416.62M | -3.75% | 1,510,353 | 109.16M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 414.66M | -1.72% | 275,964 | 69.21M |
| 255 | PBYI | Puma Biotechnology, Inc. | 405.16M | -3.16% | 602,906 | 227.18M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 390.53M | - | 307,981 | - |
| 257 | VNDA | Vanda Pharmaceuticals Inc. | 384.27M | 2.57% | 775,325 | 217.78M |
| 258 | LXEO | Lexeo Therapeutics, Inc. | 376.12M | 4.13% | 1,267,757 | - |
| 259 | HELP | Cybin Inc. | 373.76M | 2.38% | 868,362 | - |
| 260 | ABEO | Abeona Therapeutics Inc. | 373.32M | 3.80% | 1,663,332 | 14.54M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 371.62M | -2.23% | 528,153 | 9.01M |
| 262 | LYEL | Lyell Immunopharma, Inc. | 371.25M | 13.32% | 275,708 | 31.00K |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 364.74M | -1.78% | 172,001 | 51.00M |
| 264 | PALI | Palisade Bio, Inc. | 361.05M | 1.96% | 5,411,609 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 355.95M | 3.65% | 1,741,701 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 352.28M | 18.81% | 1,513,556 | 28.22M |
| 267 | FATE | Fate Therapeutics, Inc. | 352.01M | 1.00% | 2,421,452 | 6.32M |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 349.37M | 3.54% | 1,265,293 | 1.00 |
| 269 | ZNTL | Zentalis Pharmaceuticals, Inc. | 340.27M | 1.27% | 1,092,678 | 26.87M |
| 270 | OABI | OmniAb, Inc. | 336.34M | -3.73% | 666,077 | 28.94M |
| 271 | IMRX | Immuneering Corporation | 329.96M | -0.78% | 1,000,689 | - |
| 272 | IRD | Opus Genetics, Inc. | 329.65M | -0.49% | 1,032,392 | 11.98M |
| 273 | LCTX | Lineage Cell Therapeutics, Inc. | 329.07M | -0.75% | 680,001 | 14.78M |
| 274 | NMRA | Neumora Therapeutics, Inc. | 320.54M | 2.37% | 1,392,303 | - |
| 275 | ALXO | ALX Oncology Holdings Inc. | 317.57M | 7.76% | 1,816,565 | - |
| 276 | IFRX | InflaRx N.V. | 312.26M | 0.47% | 1,226,836 | 33.82K |
| 277 | BCYC | Bicycle Therapeutics plc | 305.77M | 0.69% | 507,412 | 63.50M |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 303.80M | -1.01% | 1,756,189 | - |
| 279 | GALT | Galectin Therapeutics Inc. | 303.60M | -0.43% | 437,225 | - |
| 280 | INDP | Indaptus Therapeutics, Inc. | 302.36M | -6.32% | 83,185 | - |
| 281 | MGNX | MacroGenics, Inc. | 301.92M | 3.94% | 941,308 | 157.08M |
| 282 | SABS | SAB Biotherapeutics, Inc. | 298.21M | -0.51% | 559,763 | 114.70K |
| 283 | RNAC | Cartesian Therapeutics, Inc. | 295.28M | -2.80% | 138,642 | 1.78M |
| 284 | TTRX | Turn Therapeutics Inc. | 289.24M | 26.27% | 449,865 | - |
| 285 | IVVD | Invivyd, Inc. | 277.46M | 12.93% | 12,939,265 | 55.87M |
| 286 | NAGE | Niagen Bioscience, Inc. | 275.35M | -1.43% | 818,461 | 130.42M |
| 287 | GLSI | Greenwich LifeSciences, Inc. | 272.57M | -9.15% | 228,087 | - |
| 288 | TRDA | Entrada Therapeutics, Inc. | 268.45M | -1.66% | 374,539 | 5.74M |
| 289 | SRZN | Surrozen, Inc. | 267.15M | -2.16% | 199,398 | 7.49M |
| 290 | ADAG | Adagene Inc. | 259.67M | - | 700,343 | 7.67M |
| 291 | CHRS | Coherus Oncology, Inc. | 257.60M | 7.05% | 1,526,059 | 46.88M |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 256.42M | 5.83% | 24,448 | 18.47M |
| 293 | CNXU | Conexeu Sciences Inc. | 253.94M | -12.13% | 335,952 | - |
| 294 | ACIU | AC Immune SA | 251.97M | 1.20% | 141,480 | 4.62M |
| 295 | FULC | Fulcrum Therapeutics, Inc. | 251.21M | 1.34% | 2,751,644 | 80.00M |
| 296 | AVXL | Anavex Life Sciences Corp. | 251.14M | 1.88% | 851,494 | - |
| 297 | NKTX | Nkarta, Inc. | 241.82M | 2.42% | 1,174,421 | - |
| 298 | TARA | Protara Therapeutics, Inc. | 239.99M | 4.66% | 1,192,456 | - |
| 299 | DTIL | Precision BioSciences, Inc. | 238.67M | 12.26% | 1,249,634 | 45.07M |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 237.13M | -2.94% | 259,105 | 32.72M |
| 301 | CDXS | Codexis, Inc. | 236.33M | -2.26% | 774,272 | 78.09M |
| 302 | PRQR | ProQR Therapeutics N.V. | 234.26M | -3.49% | 2,007,159 | 15.73M |
| 303 | NBP | NovaBridge Biosciences | 233.61M | 0.50% | 490,753 | - |
| 304 | QTTB | Q32 Bio Inc. | 230.95M | 5.83% | 239,399 | 53.74M |
| 305 | KROS | Keros Therapeutics, Inc. | 230.57M | 5.62% | 269,233 | 33.18M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 228.47M | 2.80% | 173,330 | 3.93M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 228.39M | 4.42% | 1,651,492 | 36.49M |
| 308 | KPTI | Karyopharm Therapeutics Inc. | 227.76M | 4.47% | 249,515 | 151.12M |
| 309 | RNA | Atrium Therapeutics, Inc. | 226.48M | 1.77% | 257,320 | 36.68M |
| 310 | CLLS | Cellectis S.A. | 226.33M | -2.13% | 31,973 | 75.11M |
| 311 | CGEN | Compugen Ltd. | 226.06M | 1.27% | 220,946 | 72.66M |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 223.20M | 3.23% | 1,041,389 | 7.15M |
| 313 | NERV | Minerva Neurosciences, Inc. | 222.23M | -3.05% | 188,422 | - |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 216.02M | 3.40% | 408,402 | 54.71M |
| 315 | NAUT | Nautilus Biotechnology, Inc. | 214.76M | -1.74% | 647,824 | - |
| 316 | ALEC | Alector, Inc. | 214.28M | -0.52% | 416,164 | 18.42M |
| 317 | NGEN | NervGen Pharma Corp. | 213.47M | -4.74% | 300,468 | - |
| 318 | IMUX | Immunic, Inc. | 209.23M | 3.36% | 262,531 | - |
| 319 | KRRO | Korro Bio, Inc. | 208.98M | 3.06% | 245,156 | 3.84M |
| 320 | HUMA | Humacyte, Inc. | 207.86M | 0.04% | 7,829,703 | 2.02M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 202.61M | - | 261,965 | 17.56M |
| 322 | TNYA | Tenaya Therapeutics, Inc. | 199.64M | 6.31% | 6,090,925 | 225.00K |
| 323 | ARMP | Armata Pharmaceuticals, Inc. | 194.93M | -2.39% | 132,802 | 5.20M |
| 324 | PYXS | Pyxis Oncology, Inc. | 194.50M | 24.80% | 2,460,869 | 13.86M |
| 325 | MDWD | MediWound Ltd. | 192.01M | 2.05% | 91,467 | 14.48M |
| 326 | CRBU | Caribou Biosciences, Inc. | 190.43M | 4.92% | 2,347,648 | 11.20M |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 190.15M | 2.61% | 696,492 | 76.38M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 185.62M | -3.75% | 440,964 | - |
| 329 | LENZ | LENZ Therapeutics, Inc. | 184.99M | 5.36% | 1,332,927 | 20.99M |
| 330 | EQ | Equillium, Inc. | 182.09M | 3.97% | 352,729 | 4.39M |
| 331 | OKUR | OnKure Therapeutics, Inc. | 176.93M | -4.78% | 370,461 | - |
| 332 | IPHA | Innate Pharma S.A. | 176.91M | 1.60% | 10,126 | 10.57M |
| 333 | OTLK | Outlook Therapeutics, Inc. | 176.46M | 2.82% | 4,760,464 | 333.14K |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 175.98M | -5.91% | 235,392 | 2.00M |
| 335 | ACOG | Alpha Cognition Inc. | 175.72M | 2.15% | 43,815 | 10.83M |
| 336 | MIST | Milestone Pharmaceuticals Inc. | 175.50M | -2.27% | 1,427,070 | 1.78M |
| 337 | CNTN | Canton Strategic Holdings, Inc. | 174.51M | -2.53% | 497,600 | - |
| 338 | NRXP | NRx Pharmaceuticals, Inc. | 174.35M | 5.45% | 964,993 | 2.29M |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 173.79M | 4.22% | 528,750 | - |
| 340 | TLSA | Tiziana Life Sciences Ltd | 162.93M | 7.69% | 139,658 | - |
| 341 | MENS | Jyong Biotech Ltd. | 159.60M | -2.27% | 46,241 | - |
| 342 | ANTX | AN2 Therapeutics, Inc. | 154.87M | -2.49% | 187,880 | - |
| 343 | KZIA | Kazia Therapeutics Limited | 150.72M | 0.84% | 281,990 | 1.27M |
| 344 | MOLN | Molecular Partners AG | 150.23M | 2.25% | 9,127 | 856.30K |
| 345 | AGEN | Agenus Inc. | 145.75M | 2.64% | 1,163,513 | 123.87M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 144.98M | 1.31% | 2,345,161 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 142.65M | -5.08% | 278,985 | - |
| 348 | PEPG | PepGen Inc. | 141.80M | 8.47% | 2,130,922 | - |
| 349 | YDES | YD Bio Limited | 140.64M | -14.53% | 428,004 | 510.36K |
| 350 | CUE | Cue Biopharma, Inc. | 140.25M | 2.74% | 74,420 | 32.73M |
| 351 | SPRB | Spruce Biosciences, Inc. | 139.73M | -2.08% | 77,035 | 697.00K |
| 352 | CNTB | Connect Biopharma Holdings Limited | 139.15M | -6.36% | 321,395 | 233.00K |
| 353 | COYA | Coya Therapeutics, Inc. | 134.88M | -0.17% | 305,922 | 7.94M |
| 354 | ALDX | Aldeyra Therapeutics, Inc. | 134.52M | -2.19% | 2,136,994 | - |
| 355 | GNLX | Genelux Corporation | 131.89M | -1.66% | 112,525 | 8.00K |
| 356 | ENGN | enGene Therapeutics Inc. | 128.62M | 0.52% | 1,408,997 | - |
| 357 | GUTS | Fractyl Health, Inc. | 126.28M | -1.23% | 442,061 | 3.00K |
| 358 | SPRO | Spero Therapeutics, Inc. | 125.07M | -1.37% | 879,819 | 61.19M |
| 359 | NMAD | NOMAD Power Solutions, Inc. | 124.31M | -16.89% | 491,190 | - |
| 360 | SEER | Seer, Inc. | 122.06M | 1.37% | 1,517,801 | 15.17M |
| 361 | PMN | ProMIS Neurosciences, Inc. | 121.51M | -1.17% | 107,636 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 119.78M | -4.53% | 88,065 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 119.19M | 5.58% | 2,201,217 | 70.00M |
| 364 | ENLV | Enlivex Ltd. | 119.08M | -3.53% | 1,150,321 | - |
| 365 | AARD | Aardvark Therapeutics, Inc. | 118.68M | -9.18% | 261,747 | - |
| 366 | VANI | Vivani Medical, Inc. | 116.42M | 3.85% | 11,555,365 | - |
| 367 | CBUS | Cibus, Inc. | 115.26M | 7.09% | 298,147 | 4.29M |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 114.92M | 3.87% | 22,463 | - |
| 369 | NTHI | NeOnc Technologies Holdings, Inc. | 112.94M | -2.57% | 71,763 | 39.99K |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 104.28M | -0.98% | 10,756 | 37.16M |
| 371 | PYPD | PolyPid Ltd. | 102.20M | -4.48% | 189,764 | - |
| 372 | ONCY | Oncolytics Biotech Inc. | 102.14M | -2.77% | 1,243,236 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 101.22M | 1.45% | 555,164 | - |
| 374 | ANIX | Anixa Biosciences, Inc. | 100.71M | -2.95% | 189,972 | - |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 99.55M | 4.31% | 1,555,034 | 65.34K |
| 376 | FBIO | Fortress Biotech, Inc. | 99.33M | 1.36% | 391,742 | 66.16M |
| 377 | ALPS | Alps Group Inc | 98.14M | 1.11% | 122,846 | 3.74M |
| 378 | ATHE | Alterity Therapeutics Limited | 98.05M | -6.79% | 19,119 | 4.43M |
| 379 | CGTX | Cognition Therapeutics, Inc. | 96.66M | 0.93% | 1,950,302 | - |
| 380 | RNTX | Rein Therapeutics Inc. | 93.97M | -1.94% | 430,777 | - |
| 381 | ICCC | ImmuCell Corporation | 93.54M | 2.78% | 37,793 | 29.93M |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 92.44M | -5.70% | 49,325 | 23.14M |
| 383 | CRDF | Cardiff Oncology, Inc. | 92.30M | 3.85% | 517,286 | 525.00K |
| 384 | OKYO | OKYO Pharma Limited | 91.84M | 8.70% | 119,662 | - |
| 385 | ACET | Adicet Bio, Inc. | 90.47M | -5.02% | 66,249 | - |
| 386 | MAIA | MAIA Biotechnology, Inc. | 89.38M | 0.68% | 457,712 | - |
| 387 | NRXS | NeurAxis, Inc. | 88.30M | -0.42% | 38,999 | 4.28M |
| 388 | RANI | Rani Therapeutics Holdings, Inc. | 87.87M | -10.55% | 1,579,084 | 3.17M |
| 389 | GOSS | Gossamer Bio, Inc. | 86.77M | -8.93% | 14,282,602 | 55.54M |
| 390 | PTHS | Pelthos Therapeutics Inc. | 85.50M | 1.11% | 36,588 | 27.70M |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | -2.36% | 48,811 | - |
| 392 | RLYB | Rallybio Corporation | 83.02M | -0.32% | 14,111 | 858.00K |
| 393 | LONA | LeonaBio, Inc. | 82.10M | 0.69% | 24,306 | - |
| 394 | ENTX | Entera Bio Ltd. | 81.82M | -2.92% | 226,089 | 42.00K |
| 395 | ANVS | Annovis Bio, Inc. | 81.68M | -2.54% | 1,628,090 | - |
| 396 | CSBR | Champions Oncology, Inc. | 81.65M | 0.51% | 6,895 | 57.95M |
| 397 | HRTX | Heron Therapeutics, Inc. | 80.58M | -1.89% | 2,632,199 | 150.71M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 79.61M | 4.49% | 433,601 | - |
| 399 | IBIO | iBio, Inc. | 78.99M | -1.85% | 463,228 | 300.00K |
| 400 | MCRB | Seres Therapeutics, Inc. | 78.83M | 5.58% | 98,947 | 1.15M |
| 401 | GANX | Gain Therapeutics, Inc. | 77.20M | - | 743,472 | - |
| 402 | VRXA | Veraxa Biotech AG | 76.41M | 38.36% | 6,194,558 | - |
| 403 | HYFT | MindWalk Holdings Corp. | 75.00M | -7.93% | 341,163 | 20.70M |
| 404 | XBIT | XBiotech Inc. | 72.71M | -1.04% | 28,994 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 71.90M | 2.61% | 283,782 | - |
| 406 | MNOV | MediciNova, Inc. | 70.88M | - | 64,965 | 596.64K |
| 407 | OSTX | OS Therapies Incorporated | 70.82M | -1.24% | 1,683,448 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 69.93M | 1.90% | 606,637 | 9.14M |
| 409 | CING | Cingulate Inc. | 68.56M | -3.96% | 471,853 | - |
| 410 | IMA | ImageneBio, Inc. | 68.46M | -0.50% | 5,878 | 800.00K |
| 411 | BYSI | BeyondSpring Inc. | 68.26M | -7.26% | 8,619 | 1.88M |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 66.13M | 2.90% | 170,688 | - |
| 413 | EDSA | Edesa Biotech, Inc. | 64.91M | 1.25% | 60,048 | - |
| 414 | EXOZ | eXoZymes, Inc. | 64.40M | -6.70% | 12,436 | -700.00 |
| 415 | CNTX | Context Therapeutics Inc. | 64.32M | 9.79% | 2,041,022 | - |
| 416 | FLNA | Filana Therapeutics, Inc. | 63.28M | 4.80% | 386,614 | - |
| 417 | ATYR | aTyr Pharma, Inc. | 59.43M | -7.31% | 2,355,212 | 190.00K |
| 418 | IMMP | Immutep Limited | 56.21M | 1.20% | 395,212 | 5.28M |
| 419 | BOLD | Boundless Bio, Inc. | 56.16M | - | 116,623 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 55.28M | -2.12% | 193,652 | 53.48M |
| 421 | ELTX | Elicio Therapeutics, Inc. | 53.40M | -15.02% | 1,407,095 | - |
| 422 | MREO | Mereo BioPharma Group plc | 53.39M | 5.65% | 2,045,812 | 500.00K |
| 423 | INKT | MiNK Therapeutics, Inc. | 52.91M | -8.13% | 16,946 | - |
| 424 | TIL | Instil Bio, Inc. | 52.56M | 0.39% | 13,183 | - |
| 425 | ABVC | ABVC BioPharma, Inc. | 51.04M | 6.32% | 496,219 | 797.92K |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 49.69M | 5.60% | 287,566 | 22.33M |
| 427 | RADX | Radiopharm Theranostics Limited | 49.16M | -2.53% | 19,802 | 10.86M |
| 428 | IBO | Impact BioMedical Inc. | 48.70M | -5.30% | 33,799 | 39.00K |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 48.43M | 4.35% | 225,009 | - |
| 430 | PDSB | PDS Biotechnology Corporation | 46.61M | -1.30% | 184,963 | - |
| 431 | CRVO | CervoMed Inc. | 46.26M | -4.20% | 282,838 | 2.09M |
| 432 | INMB | INmune Bio Inc. | 46.26M | 4.50% | 1,796,505 | 50.00K |
| 433 | VERU | Veru Inc. | 46.22M | 1.77% | 285,696 | 16.89M |
| 434 | LTRN | Lantern Pharma Inc. | 45.55M | -9.16% | 224,009 | - |
| 435 | ELOX | Eloxx Pharmaceuticals, Inc. | 44.20M | -5.28% | 66,366 | - |
| 436 | HYPD | Hyperion DeFi, Inc. | 43.35M | -12.27% | 479,423 | 1.04M |
| 437 | RNXT | RenovoRx, Inc. | 41.83M | -2.12% | 407,229 | 1.49M |
| 438 | APLM | Apollomics, Inc. | 41.57M | -2.22% | 6,781 | 8.84M |
| 439 | GRCE | Grace Therapeutics, Inc. | 40.85M | -0.79% | 165,699 | - |
| 440 | ESLA | Estrella Immunopharma, Inc. | 39.16M | -10.78% | 37,711 | - |
| 441 | DYAI | Dyadic International, Inc. | 38.63M | 9.55% | 1,120,174 | 3.81M |
| 442 | GNTA | Genenta Science S.p.A. | 37.98M | -4.17% | 79,222 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 37.69M | 4.10% | 819,925 | 4.71M |
| 444 | NTRB | Nutriband Inc. | 36.83M | -3.50% | 15,947 | 1.80M |
| 445 | ACTU | Actuate Therapeutics, Inc. | 36.37M | 8.57% | 109,475 | - |
| 446 | NNVC | NanoViricides, Inc. | 33.49M | -2.00% | 399,943 | - |
| 447 | LITS | Lite Strategy, Inc. | 33.05M | -1.30% | 220,762 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 32.94M | 9.26% | 228,039 | 90.00K |
| 449 | SER | Serina Therapeutics, Inc. | 32.54M | 11.28% | 99,658 | 130.00K |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 31.46M | -6.48% | 111,672 | 38.00K |
| 451 | DARE | Daré Bioscience, Inc. | 30.71M | -1.44% | 138,450 | 1.16M |
| 452 | KYNB | Kyntra Bio, Inc. | 30.32M | 3.31% | 57,989 | 7.44M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 30.16M | -0.29% | 330,851 | - |
| 454 | LSTA | Lisata Therapeutics, Inc. | 29.78M | -2.39% | 31,532 | 170.00K |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 29.08M | 54.23% | 70,894,178 | - |
| 456 | GRDX | GridAI Technologies Corp. | 28.94M | -2.25% | 48,396 | - |
| 457 | PLRZ | Polyrizon Ltd. | 28.55M | 0.26% | 66,562 | - |
| 458 | KALA | KALA BIO, Inc. | 28.07M | -1.95% | 71,259 | - |
| 459 | MRKR | Marker Therapeutics, Inc. | 28.01M | 13.51% | 228,676 | 3.55M |
| 460 | IGC | IGC Pharma, Inc. | 27.83M | -1.07% | 459,108 | 1.11M |
| 461 | EVAX | Evaxion A/S | 27.61M | -2.07% | 10,698 | 7.53M |
| 462 | AKTX | Akari Therapeutics, Plc | 27.10M | 42.02% | 150,942 | - |
| 463 | PSTV | Plus Therapeutics, Inc. | 26.98M | -3.21% | 84,373 | 5.18M |
| 464 | BRNS | Barinthus Biotherapeutics plc | 25.69M | -0.25% | 7,419 | 14.97M |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 25.03M | 1.74% | 84,941 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 24.72M | - | 61,883 | - |
| 467 | TVGN | Tevogen Bio Holdings Inc. | 23.03M | -6.14% | 11,335 | - |
| 468 | CVM | CEL-SCI Corporation | 22.37M | 0.79% | 343,748 | - |
| 469 | VYNE | VYNE Therapeutics Inc. | 22.34M | 0.33% | 50,963 | 454.00K |
| 470 | PLUR | Pluri Inc. | 22.33M | -5.05% | 5,264 | 1.08M |
| 471 | QNTM | Quantum BioPharma Ltd. | 21.83M | -3.49% | 57,885 | - |
| 472 | NCEL | NewcelX Ltd. | 21.59M | 2.69% | 27,862 | - |
| 473 | CLRB | Cellectar Biosciences, Inc. | 21.58M | -2.53% | 26,435 | - |
| 474 | ATOS | Atossa Therapeutics, Inc. | 21.44M | 9.21% | 426,193 | - |
| 475 | CELU | Celularity Inc. | 21.04M | -9.16% | 122,017 | 26.55M |
| 476 | ICU | SeaStar Medical Holding Corporation | 20.38M | 6.51% | 170,928 | 1.44M |
| 477 | LPCN | Lipocine Inc. | 20.36M | - | 84,400 | 2.00M |
| 478 | LGVN | Longeveron Inc. | 19.98M | -2.66% | 85,829 | 1.22M |
| 479 | CMMB | Chemomab Therapeutics Ltd. | 19.95M | 15.42% | 295,178 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 19.40M | 4.36% | 98,313 | -13.27K |
| 481 | AEON | AEON Biopharma, Inc. | 18.42M | -4.08% | 10,453 | - |
| 482 | PTN | Palatin Technologies, Inc. | 18.24M | -0.77% | 15,790 | 12.88M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 17.98M | -5.83% | 429,997 | 345.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.37M | -0.04% | 335,165 | - |
| 485 | QNCX | Quince Therapeutics, Inc. | 17.11M | 3.06% | 40,476 | - |
| 486 | HOWL | Werewolf Therapeutics, Inc. | 16.72M | 7.50% | 1,850,349 | 1.14M |
| 487 | GTBP | GT Biopharma, Inc. | 16.59M | -6.08% | 771,978 | - |
| 488 | BIVI | BioVie Inc. | 16.29M | 2.86% | 247,760 | - |
| 489 | PASG | Passage Bio, Inc. | 16.04M | 6.38% | 68,264 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 16.02M | -3.95% | 168,824 | 5.61M |
| 491 | MLEC | Moolec Science SA | 16.00M | -0.26% | 1,889 | 7.83M |
| 492 | HIND | Vyome Holdings, Inc. | 15.44M | -1.35% | 4,955 | 152.72K |
| 493 | CALC | CalciMedica, Inc. | 15.10M | -3.25% | 452,652 | - |
| 494 | CYCN | Cyclerion Therapeutics, Inc. | 14.76M | 0.58% | 11,242 | 1.99M |
| 495 | TPST | Tempest Therapeutics, Inc. | 14.67M | -7.39% | 155,553 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 14.06M | -1.92% | 29,470 | 225.00K |
| 497 | INAB | IN8bio, Inc. | 13.69M | -3.47% | 66,147 | - |
| 498 | JSPR | Jasper Therapeutics, Inc. | 13.49M | 3.37% | 196,473 | - |
| 499 | LEXX | Lexaria Bioscience Corp. | 13.14M | -5.22% | 16,936 | 368.00K |
| 500 | BLRX | BioLineRx Ltd. | 12.95M | - | 14,622 | 1.40M |